Zoetis's Blueprint for Resilience: How Sustainability Became Core Strategy

PARSIPPANY, NJ – June 04, 2026 – When the world's largest animal health company, Zoetis, released its 2025 Sustainability Report, it did more than just publish a list of environmental and social achievements. It provided a detailed look into the machinery of a modern global enterprise where sustainability is no longer a peripheral corporate function but a core component of business strategy, risk mitigation, and long-term value creation. The report, marking the culmination of the company's initial five-year 'Driven to Care' goals set in 2021, reveals a sophisticated evolution from broad aspirations to a sharpened, data-driven strategy that directly impacts innovation, public health, and the economic landscape of animal care.

The Strategic Evolution of 'Driven to Care'

At its core, the latest chapter of 'Driven to Care' signifies a strategic pivot. While the foundational pillars—Communities, Animals, and the Planet—remain, the approach has matured. The company has moved beyond simply setting targets to deeply embedding sustainability objectives into its operational and financial planning. Executive team members now have performance objectives tied directly to advancing these goals, a critical step that transforms ESG from a communications exercise into a mandate for the C-suite. This integration is the key to understanding the report not as a retrospective of good deeds, but as a forward-looking statement on business resilience.

This evolution is a direct response to a confluence of global trends: increasing investor scrutiny on ESG performance, growing consumer demand for ethically produced food, and the undeniable economic risks posed by climate change and zoonotic diseases. By sharpening its strategic priorities, the Parsippany-based firm is positioning itself to not only weather these shifts but to capitalize on them. The strategy is designed to create a virtuous cycle: investing in the veterinary community ensures a healthy pipeline of customers and talent, innovating against emerging diseases protects the global food supply and opens new markets, and reducing the company's environmental footprint drives operational efficiency and mitigates regulatory risk.

Innovation as a Pillar of Public Health

Nowhere is the intersection of business and societal impact more apparent than in the 'Animals' pillar of the report. The recent regulatory milestones for Zoetis are not just product line extensions; they are critical interventions in public health and food security. The company secured conditional licenses from U.S. and Canadian authorities for an avian influenza (H5N2) vaccine for poultry, alongside a U.S. conditional license for dairy cattle. This is a crucial development in the global fight against Highly Pathogenic Avian Influenza (HPAI), a virus that has devastated poultry populations and poses a persistent zoonotic threat.

The use of the 'conditional license' pathway is itself a strategic maneuver, allowing for the rapid deployment of a vaccine during an outbreak, a necessity when dealing with fast-moving infectious diseases. The expansion to dairy cattle, following recent H5N1 outbreaks in herds, demonstrates a proactive response to the evolving nature of the virus. By developing these tools, Zoetis is not only serving its agricultural customer base but also reinforcing the 'One Health' principle—the concept that animal health, human health, and environmental health are inextricably linked. Protecting livestock from HPAI reduces the viral reservoir, lowering the probability of mutations that could lead to more efficient human-to-human transmission.

Similarly, the first-ever conditional FDA approval for Dectomax®-CA1 Injectable to treat New World screwworm infestations in cattle addresses a devastating parasitic threat. Screwworm can cause significant economic losses for livestock producers and poses a risk to wildlife and even humans. Securing this approval creates a powerful tool for controlling outbreaks, protecting agricultural economies, and demonstrating the company's R&D prowess in tackling niche but critical animal health challenges.

Deconstructing the Environmental Paw Print

On the environmental front, Zoetis's reported progress demonstrates a clear link between sustainability and economic efficiency. The headline figure—a 29% reduction in Scope 1 and 2 emissions since 2021—is the result of over 100 discrete carbon reduction projects. These are not abstract commitments but tangible investments in energy efficiency and process optimization across manufacturing and R&D sites that are expected to save approximately 53,000 gigajoules of energy annually. In business terms, less energy used is less money spent.

The company's aggressive pursuit of its RE100 commitment—a global initiative to source 100% renewable electricity—further illustrates this point. By reaching 85% renewable electricity usage in 2025, up from 80% the prior year, Zoetis is de-risking its operations from volatile fossil fuel markets and positioning itself favorably for a future of stricter carbon regulations. This progress is achieved through a pragmatic mix of financial power purchase agreements, direct retail supply contracts, and on-site solar generation.

Even logistical operations are being re-engineered for sustainability and efficiency. The implementation of a single-size, dual-temperature shipper at major U.S. distribution centers allows ambient and cold-chain products to be sent in the same box. This seemingly minor change has a cascading effect, reducing packaging materials, lowering shipping weight and costs, and shrinking the overall carbon footprint of its distribution network. It's a prime example of how operationalizing sustainability can yield direct bottom-line benefits.

Investing in the Human Capital of Animal Health

Perhaps the most far-sighted element of the 'Driven to Care' strategy is its deep investment in the human infrastructure of the animal health industry. The Zoetis Foundation's distribution of $35 million in grants between 2021 and 2025 goes far beyond standard corporate philanthropy. It's a strategic allocation of capital to solve a systemic crisis facing the veterinary profession: staggering student debt, burnout, and workforce shortages, particularly in rural and food animal medicine.

By providing $12.8 million in scholarships to over 2,200 students through partnerships with groups like the American Veterinary Medical Foundation (AVMF), the foundation is directly addressing the financial barriers to entry. Initiatives like the Educational Debt Relief Grant Program for swine veterinarians tackle the problem from the other end, helping to retain professionals in critical, underserved sectors. Furthermore, grants to organizations like Not One More Vet (NOMV) and Vetlife directly confront the profession's acute mental health challenges. This is not just altruism; it is a long-term investment in the well-being and stability of the company's primary customer base and the very ecosystem in which it operates.

“At Zoetis, we’re leading with purpose—turning Driven to Care into measurable impact for Communities, Animals, and the Planet through innovation, partnership, and global execution,” said Jeannette Ferran Astorga, Executive Vice President, Corporate Affairs, and Chief Sustainability Officer of Zoetis. This sentiment is echoed in the more than 72,000 colleague volunteer hours logged since 2021, indicating a strong internal culture that reinforces the external strategy. By nurturing the entire animal health ecosystem, Zoetis is ensuring its own future resilience and leadership in an increasingly complex world.